15-31038110-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001252024.2(TRPM1):​c.2373T>C​(p.Tyr791Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.235 in 1,613,592 control chromosomes in the GnomAD database, including 46,541 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.24 ( 4502 hom., cov: 33)
Exomes 𝑓: 0.23 ( 42039 hom. )

Consequence

TRPM1
NM_001252024.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.988

Publications

12 publications found
Variant links:
Genes affected
TRPM1 (HGNC:7146): (transient receptor potential cation channel subfamily M member 1) This gene encodes a member of the transient receptor potential melastatin subfamily of transient receptor potential ion channels. The encoded protein is a calcium permeable cation channel that is expressed in melanocytes and may play a role in melanin synthesis. Specific mutations in this gene are the cause autosomal recessive complete congenital stationary night blindness-1C. The expression of this protein is inversely correlated with melanoma aggressiveness and as such it is used as a prognostic marker for melanoma metastasis. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Oct 2011]
TRPM1 Gene-Disease associations (from GenCC):
  • congenital stationary night blindness 1C
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • TRPM1-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • congenital stationary night blindness
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 15-31038110-A-G is Benign according to our data. Variant chr15-31038110-A-G is described in ClinVar as [Benign]. Clinvar id is 315512.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.254 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRPM1NM_001252024.2 linkc.2373T>C p.Tyr791Tyr synonymous_variant Exon 19 of 28 ENST00000256552.11 NP_001238953.1 Q7Z4N2-6
TRPM1NM_001252020.2 linkc.2424T>C p.Tyr808Tyr synonymous_variant Exon 18 of 27 NP_001238949.1 Q7Z4N2-5
TRPM1NM_002420.6 linkc.2307T>C p.Tyr769Tyr synonymous_variant Exon 18 of 27 NP_002411.3 Q7Z4N2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRPM1ENST00000256552.11 linkc.2373T>C p.Tyr791Tyr synonymous_variant Exon 19 of 28 1 NM_001252024.2 ENSP00000256552.7 Q7Z4N2-6

Frequencies

GnomAD3 genomes
AF:
0.239
AC:
36309
AN:
152022
Hom.:
4496
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.258
Gnomad AMI
AF:
0.270
Gnomad AMR
AF:
0.251
Gnomad ASJ
AF:
0.231
Gnomad EAS
AF:
0.0110
Gnomad SAS
AF:
0.146
Gnomad FIN
AF:
0.249
Gnomad MID
AF:
0.212
Gnomad NFE
AF:
0.247
Gnomad OTH
AF:
0.253
GnomAD2 exomes
AF:
0.226
AC:
56427
AN:
249138
AF XY:
0.226
show subpopulations
Gnomad AFR exome
AF:
0.257
Gnomad AMR exome
AF:
0.273
Gnomad ASJ exome
AF:
0.235
Gnomad EAS exome
AF:
0.00863
Gnomad FIN exome
AF:
0.254
Gnomad NFE exome
AF:
0.255
Gnomad OTH exome
AF:
0.228
GnomAD4 exome
AF:
0.235
AC:
343354
AN:
1461452
Hom.:
42039
Cov.:
36
AF XY:
0.233
AC XY:
169192
AN XY:
727020
show subpopulations
African (AFR)
AF:
0.263
AC:
8809
AN:
33468
American (AMR)
AF:
0.269
AC:
12007
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.235
AC:
6131
AN:
26132
East Asian (EAS)
AF:
0.0220
AC:
874
AN:
39694
South Asian (SAS)
AF:
0.160
AC:
13774
AN:
86244
European-Finnish (FIN)
AF:
0.259
AC:
13806
AN:
53400
Middle Eastern (MID)
AF:
0.266
AC:
1534
AN:
5768
European-Non Finnish (NFE)
AF:
0.246
AC:
273079
AN:
1111656
Other (OTH)
AF:
0.221
AC:
13340
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
12946
25892
38838
51784
64730
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9178
18356
27534
36712
45890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.239
AC:
36361
AN:
152140
Hom.:
4502
Cov.:
33
AF XY:
0.238
AC XY:
17703
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.258
AC:
10707
AN:
41500
American (AMR)
AF:
0.251
AC:
3834
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.231
AC:
802
AN:
3472
East Asian (EAS)
AF:
0.0110
AC:
57
AN:
5186
South Asian (SAS)
AF:
0.148
AC:
713
AN:
4816
European-Finnish (FIN)
AF:
0.249
AC:
2636
AN:
10570
Middle Eastern (MID)
AF:
0.211
AC:
62
AN:
294
European-Non Finnish (NFE)
AF:
0.247
AC:
16768
AN:
67988
Other (OTH)
AF:
0.253
AC:
536
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1414
2828
4241
5655
7069
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
368
736
1104
1472
1840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.245
Hom.:
19709
Bravo
AF:
0.244
Asia WGS
AF:
0.0980
AC:
343
AN:
3478
EpiCase
AF:
0.252
EpiControl
AF:
0.259

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Congenital stationary night blindness 1C Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.56
DANN
Benign
0.55
PhyloP100
-0.99
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12913672; hg19: chr15-31330313; API